The Economic Times
English EditionEnglish Editionहिन्दी
| 29 November, 2020, 01:28 PM IST | E-Paper
Search
+

Indraprastha Medical Corporation Ltd.

  • 51.65-0.40 (-0.77%)
  • Volume: 1,73,669
  • Closed
  • Last Updated On: 27 Nov, 2020, 03:56 PM IST
  • Overview
  • News
  • Financials
  • Technicals
  • Peers
  • Shareholdings
  • MF
  • Corporate Actions
  • About

Insights

View All
  • Company delivered ROE of 16.28% in year ending Mar 31, 2020 outperforming its 5 year avg. of 12.0%. (Source: Standalone Financials)

  • Company witnessed QoQ revenue growth of 49.56%, which is highest in the last 3 years. (Source: Standalone Financials)

  • Stock gave a 3 year return of -1.81% as compared to Nifty Smallcap 100 which gave a return of -24.84%. (as of last trading session)

  • Company has spent less than 1% of its operating revenues towards interest expenses and 25.75% towards employee cost in the year ending Mar 31, 2020. (Source: Standalone Financials)

InsightsIndraprastha Medical Corporation Ltd.

  • ROE Outperforming 5 Year Average

    Company delivered ROE of 16.28% in year ending Mar 31, 2020 outperforming its 5 year avg. of 12.0%. (Source: Standalone Financials)

  • Quarterly Topline Performance

    Company witnessed QoQ revenue growth of 49.56%, which is highest in the last 3 years. (Source: Standalone Financials)

  • Stock Returns vs Nifty Smallcap 100

    Stock gave a 3 year return of -1.81% as compared to Nifty Smallcap 100 which gave a return of -24.84%. (as of last trading session)

  • Employee & Interest Expense

    Company has spent less than 1% of its operating revenues towards interest expenses and 25.75% towards employee cost in the year ending Mar 31, 2020. (Source: Standalone Financials)

Do you find these insights useful?

  • hate it

  • meh

  • love it

Key Metrics

  • PE Ratio

    PE Ratio

    This is a ratio arrived at by dividing the current market price of a stock by its latest (annual or annualized) earnings per share. Here we have taken the TTM (trailing twelve months) adjusted earnings per share.

    (x)
    -62.47
  • EPS - TTM

    EPS - TTM

    Earnings per share (TTM) tells the profit after tax earned on a per share basis by a stock over the last twelve months or four quarters.

    (₹)
    -0.83
  • MCap

    MCap

    MCap or Market capitalization of a stock is calculated by multiplying the total number of shares outstanding of that particular stock with its current market price.

    (₹ Cr.)
    472.57
  • Sectoral MCap Rank

    Sectoral MCap Rank

    This is the ranking of a company within its sector based on MCap or Market capitalization. Higher the market capitalization of a company, higher the rank it is assigned.

    12
  • PB Ratio

    PB Ratio

    Price to Book represents the ratio of current market price of a stock to its book value per share. The book value itself is arrived at by dividing the net worth of a company by the total number of shares outstanding of the company at that time.

    (x)
    1.77
  • Div Yield

    Dividend Yield

    Dividend Yield calculates the amount of full year dividend declared by a company as a percentage of the current market price of a stock. All other things being equal, higher the dividend yield of the stock, the better it is for investors.

    (%)
    0.00
  • Face Value

    Face Value

    Face value of a stock is the value ascribed to the stock as per the balance sheet of the company. The dividend declared by a company is usually declared as a percentage of face value.

    (₹)
    10.00
  • Beta

    Beta

    1 Month0.31
    3 Months0.66
    6 Months0.63
    1 Year0.64
    3 Years0.77

    0.31
  • VWAP

    VWAP

    Volume Weighted Average Price represents the average price of a security over a particular time period (example one trading day) weighted by the volume traded at each price point.

    (₹)
    52.18
  • 52W H/L

    52W H/L

    This represents the 52 week high and low price of the security. It is also the 1 year high and low of the security. This represents the highest and lowest price touched by the security during the past 52 weeks or 1 year including today.

    (₹)
    65.00 / 28.00

Returns

  • 1 Day-0.77%
  • 1 Week-0.58%
  • 1 Month3.3%
  • 3 Months-2.73%
  • 1 Year23.56%
  • 3 Years1.67%
  • 5 Years-26.69%

Financials

  • Income (P&L)
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Insights

    • Quarterly Topline Performance

      Company witnessed QoQ revenue growth of 49.56%, which is highest in the last 3 years. (Source: Standalone Financials)
    • Employee & Interest Expense

      Company has spent less than 1% of its operating revenues towards interest expenses and 25.75% towards employee cost in the year ending Mar 31, 2020. (Source: Standalone Financials)
    Quarterly | AnnualSep 2020Jun 2020Mar 2020Dec 2019Sep 2019
    Total Income141.2194.42200.66210.51216.30
    Total Income Growth (%)49.56-52.95-4.68-2.686.03
    Total Expenses139.93127.52191.22195.17201.87
    Total Expenses Growth (%)9.73-33.31-2.02-3.326.76
    EBIT1.29-33.109.4415.3414.43
    EBIT Growth (%)--450.75-38.486.34-3.19
    PAT0.44-25.196.5010.6817.93
    PAT Growth (%)--487.84-39.17-40.43110.28
    EBIT Margin (%)0.91-35.064.707.296.67
    Net Profit Margin (%)0.31-26.683.245.078.29
    Basic EPS (₹)0.05-2.750.711.161.96
    Quarterly | Annual FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
    Total Revenue831.46788.64753.45766.17757.57
    Total Revenue Growth (%)5.434.67-1.661.146.05
    Total Expenses783.26744.02719.45725.36718.82
    Total Expenses Growth (%)5.273.42-0.810.918.12
    Profit after Tax (PAT)43.6228.4121.1026.2524.43
    PAT Growth (%)53.5434.64-19.597.42-24.80
    Operating Profit Margin (%)6.516.535.706.366.11
    Net Profit Margin (%)5.253.602.803.423.23
    Basic EPS (₹)4.763.102.302.862.67

    All figures in Rs Cr, unless mentioned otherwise

    No reported Profit & Loss Statement are available.

  • Annual FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
    Total Assets448.99422.37432.27458.44460.50
    Total Assets Growth (%)6.30-2.29-5.71-0.450.34
    Total Liabilities181.19178.33199.96227.62236.75
    Total Liabilities Growth (%)1.60-10.82-12.15-3.86-10.38
    Total Equity267.80244.04232.31230.83223.75
    Total Equity Growth (%)9.745.050.643.1614.88
    Current Ratio (x)1.011.090.960.850.80
    Total Debt to Equity (x)0.010.060.260.280.21
    Contingent Liabilities61.6671.4862.5857.648.90

    All figures in Rs Cr, unless mentioned otherwise

    No reported Balance Sheet are available.

  • Insights

    • Debt Coverage Capability

      Company is able to pay off its debt obligations within 1 year with latest operating cash flow of Rs 86.45 Cr. (Source: Standalone Financials)
    • Increase in Cash from Investing

      Company has used Rs 40.19 cr for investing activities which is an YoY increase of 140.69%. (Source: Standalone Financials)
    Annual FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
    Net Cash flow from Operating Activities86.4575.1947.7027.6462.26
    Net Cash used in Investing Activities-40.19-16.70-29.90-22.40-32.69
    Net Cash flow from Financing Activities-42.74-44.18-17.22-5.39-30.03
    Net Cash Flow3.5114.300.58-0.15-0.46
    Closing Cash & Cash Equivalent20.3316.822.521.942.09
    Closing Cash & Cash Equivalent Growth (%)20.89568.4429.85-7.388.26
    Total Debt/ CFO (x)0.050.201.252.340.76

    All figures in Rs Cr, unless mentioned otherwise

    No reported Cash Flow Statement are available.

  • Insights

    • ROE Outperforming 5 Year Average

      Company delivered ROE of 16.28% in year ending Mar 31, 2020 outperforming its 5 year avg. of 12.0%. (Source: Standalone Financials)
    Annual FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
    Return on Equity (%)16.2811.649.0811.3710.91
    Return on Capital Employed (%)17.4817.2614.6017.8617.10
    Return on Assets (%)9.716.724.885.725.30
    Interest Coverage Ratio (x)9.147.494.826.166.22
    Asset Turnover Ratio (x)185.02186.60174.11167.02164.05
    Price to Earnings (x)7.1412.3821.0118.5519.53
    Price to Book (x)1.161.441.912.112.13
    EV/EBITDA (x)3.344.246.726.876.34
    EBITDA Margin (%)10.4810.309.7710.3510.78

    No reported Financial Ratios are available.

Financial InsightsIndraprastha Medical Corporation Ltd.

  • Income (P&L)
  • Cash Flow
  • Ratios
    • Quarterly Topline Performance

      Company witnessed QoQ revenue growth of 49.56%, which is highest in the last 3 years. (Source: Standalone Financials)

    • Employee & Interest Expense

      Company has spent less than 1% of its operating revenues towards interest expenses and 25.75% towards employee cost in the year ending Mar 31, 2020. (Source: Standalone Financials)

    • Debt Coverage Capability

      Company is able to pay off its debt obligations within 1 year with latest operating cash flow of Rs 86.45 Cr. (Source: Standalone Financials)

    • Increase in Cash from Investing

      Company has used Rs 40.19 cr for investing activities which is an YoY increase of 140.69%. (Source: Standalone Financials)

    • ROE Outperforming 5 Year Average

      Company delivered ROE of 16.28% in year ending Mar 31, 2020 outperforming its 5 year avg. of 12.0%. (Source: Standalone Financials)

Do you find these insights useful?

  • hate it

  • meh

  • love it

Technicals

  • Buy / Sell Signals
  • Price Analysis
  • Pivot Levels & ATR
  • Chart
  • Stock doesn't have any Buy/Sell Signals.

  • Price Analysis Data details are not available.

  • Pivot Levels

    R1R2R3PIVOTS1S2S3
    Classic-------

    Average True Range

    5 DAYS14 DAYS28 DAYS
    ATR---

Peer Comparison

  • Stock Performance
  • Ratio Performance
  • Insights

    • Stock Returns vs Nifty Smallcap 100

      Stock gave a 3 year return of -1.81% as compared to Nifty Smallcap 100 which gave a return of -24.84%. (as of last trading session)
    • Stock Returns vs S&P BSE Healthcare

      Stock generated -1.81% return as compared to S&P BSE Healthcare which gave investors 44.76% return over 3 year time period. (as of last trading session)
    • 1D
    • 1W
    • 1M
    • 3M
    • 6M
    • 1Y
    • 5Y
  • Insights

    • Stock Returns vs Nifty Smallcap 100

      Stock gave a 3 year return of -1.81% as compared to Nifty Smallcap 100 which gave a return of -24.84%. (as of last trading session)
    • Stock Returns vs S&P BSE Healthcare

      Stock generated -1.81% return as compared to S&P BSE Healthcare which gave investors 44.76% return over 3 year time period. (as of last trading session)

    Ratio Performance

    NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
    Indraprastha Med-62.471.1616.2817.489.712.746.515.254.761.010.010.05
    Apollo Hospital199.684.7413.6211.044.0115.548.843.8632.701.131.002.59
    Fortis Health-37.511.430.864.220.51-0.387.991.710.770.360.207.68
    Aster DM Health37.991.659.548.142.2213.578.113.605.511.100.862.03
    Narayana Hrud-98.984.4510.4611.384.1118.268.343.915.860.980.551.42
    Add More
    Annual Ratios (%)

    Choose from Peers

    • Healthcare Global
    • Shalby
    • Sakar Healthcare
    • Lotus Eye Hosp

    Choose from Stocks

    Peers InsightsIndraprastha Medical Corporation Ltd.

    • Stock Returns vs Nifty Smallcap 100

      Stock gave a 3 year return of -1.81% as compared to Nifty Smallcap 100 which gave a return of -24.84%. (as of last trading session)

    • Stock Returns vs S&P BSE Healthcare

      Stock generated -1.81% return as compared to S&P BSE Healthcare which gave investors 44.76% return over 3 year time period. (as of last trading session)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Shareholding Pattern

    • QOQ Change
    • Total Shareholdings
    • Showing Shareholding as on 30 Sep 2020
      Category31 Dec 201931 Mar 202030 Jun 202030 Sep 2020
      Promoters51.0051.0051.0051.00
      Pledge0.000.000.000.00
      FII0.000.000.000.00
      DII0.200.120.160.02
      Mutual Funds0.000.000.000.00
      Others48.8048.8848.8448.98
    • Showing Shareholding as on 30 Sep 2020
      CategoryNo. of SharesPercentage% Change QoQ
      Promoters4,67,51,70051.00 %0.00
      Pledge00.00 %0.00
      DII16,5940.02 %-0.14
      Others4,49,04,70648.98 %0.14

    MF Ownership

    No Mutual Fund schemes are currently holding this stock in their portfolio.

    Corporate Actions

    • Board Meeting/AGM
    • Dividends
    • Others
    • Meeting DateAnnounced onPurposeDetails
      Nov 10, 2020Nov 04, 2020Board MeetingQuarterly Results
      Sep 29, 2020Sep 01, 2020AGMBook closure from Sep 19, 2020 to Sep 29, 2020
      Aug 24, 2020Aug 14, 2020Board MeetingQuarterly Results
      May 23, 2020May 14, 2020Board MeetingAudited Results
      Feb 03, 2020Jan 10, 2020Board MeetingQuarterly Results
    • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
      Final16%1.6Sep 12, 2019May 08, 2019
      Final15%1.5Sep 12, 2018May 09, 2018
      Final18%1.8Sep 14, 2017Jun 01, 2017
      Final18%1.8Aug 18, 2016May 23, 2016
      Final18%1.8Sep 16, 2015May 26, 2015
    • No other corporate actions details are available.

    About Indraprastha Medical Corporation Ltd.

    Indraprastha Medical Corporation Ltd., incorporated in the year 1988, is a Small Cap company (having a market cap of Rs 473.49 Crore) operating in Hospitals & Allied Services sector. Indraprastha Medical Corporation Ltd. key Products/Revenue Segments include Hospital Services which contributed Rs 796.69 Crore to Sales Value (95.89 % of Total Sales), Licence Fees which contributed Rs 17.82 Crore to Sales Value (2.14 % of Total Sales), Export Incentives which contributed Rs 9.45 Crore to Sales Value (1.13 % of Total Sales), Miscellaneous Income which contributed Rs 4.31 Crore to Sales Value (0.51 % of Total Sales) and Other Operating Revenue which contributed Rs 2.49 Crore to Sales Value (0.29 % of Total Sales)for the year ending 31-Mar-2020. Show More

    • Executives
    • Auditors
    • AK

      Ajay Kumar Singhal

      Vice President & Co. Secretary
      AK

      Ajay Kumar Singhal

      Secretary
      AR

      Arun Rai

      Director
      CP

      Chander Prakash Tyagi

      Chief Financial Officer
      Show More
    • S N Dhawan & Co. LLP

    Industry

    Hospital

    Key Indices Listed on

    S&P BSE SmallCap, S&P BSE Healthcare, S&P BSE AllCap, + 1 more

    Address

    Sarita Vihar,Delhi-Mathura Road,New Delhi, Delhi - 110076

    Indraprastha Med Share Price Update

    Indraprastha Medical Corporation Ltd. share price moved down by -0.77% from its previous close of Rs 52.05. Indraprastha Medical Corporation Ltd. stock last traded price is 51.65

    Share PriceValue
    Today/Current/Last51.65
    Previous Day52.05

    Trending in Markets

    DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

    DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

    By using this site, you agree to the Terms of Service and Privacy Policy.

    The Economic Times